---
schema_version: "secwatch.filing_event.v1"
accession: "0001568651-26-000014"
form_type: "8-K"
ticker: "OSCR"
cik: "0001568651"
company_name: "Oscar Health, Inc."
filed_at: "2026-03-02T23:59:59+00:00"
generated_at: "2026-05-15T22:39:13.593519+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Oscar Health reaffirms FY 2026 guidance at Raymond James conference

## Summary
- Participating in the 2026 Raymond James Institutional Investors Conference on March 2, 2026.
- Reaffirming full-year 2026 guidance previously announced on Feb 10, 2026 in Q4/FY2025 earnings release.
- No new financial metrics or changes to prior guidance disclosed in this filing.

## SEC filing metadata
- accession: 0001568651-26-000014
- form_type: 8-K
- ticker: OSCR
- cik: 0001568651
- company_name: Oscar Health, Inc.
- filed_at: 2026-03-02T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 7.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1568651/000156865126000014/0001568651-26-000014-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1568651/000156865126000014/oscr-20260302.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001568651-26-000014
- JSON: https://secwatch.observer/filing/0001568651-26-000014.json
- Plain text: https://secwatch.observer/filing/0001568651-26-000014.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.